Clinical trial
Randomized Controlled Trial to Evaluate the Effect of Premedication With N-acetylcysteine and Simethicone on Mucosal Visibility During Elective Upper Gastrointestinal Endoscopy Using the TUGS Score
NCT07245095 is registered in ClinicalTrials.gov with Hospital General de Mexicali as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Trial to Evaluate the Effect of Premedication With N-acetylcysteine and Simethicone on Mucosal Visibility During Elective Upper Gastrointestinal Endoscopy Using the TUGS Score
- Lead sponsor
- Hospital General de Mexicali
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- September 12, 2025
- Completion date
- December 31, 2026
- Enrollment
- 132 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
esophagogastroduodenoscopy, esophagogastroduodensocopy (egd) procedure, gastritis associated with helicobacter pylori, lesions in the esophagus, stomach, duodenum or rectum, n-acetylcysteine, placebo - control, premedication, simethicone, tumor gastric, visualization